{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:38:25Z","timestamp":1793122705255,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006342","name":"Association Vaincre la Mucoviscidose","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006342","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.diabres.2026.113544","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:57:14Z","timestamp":1788278234000},"page":"113544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Postprandial ultra-fast insulin versus mealtime fast-acting insulin in adults with cystic fibrosis-related diabetes: A randomized multicentre crossover trial"],"prefix":"10.1016","volume":"241","author":[{"given":"Luc","family":"Rakotoarisoa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Mulette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Chiron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Ramel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Ronsin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Stremler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Gabsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Mely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismael Da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2026.113544_b0005","unstructured":"Cystic Fibrosis Foundation Patient Registry Annual Data Report. Cystic Fibrosis Foundation, 2024. Available at:https:\/\/www.cff.org\/medical-professionals\/2024-patient-registry."},{"issue":"14","key":"10.1016\/j.diabres.2026.113544_b0010","article-title":"Pancreas and islet morphology in cystic fibrosis: clues to the etiology of cystic fibrosis-related diabetes","volume":"23","author":"Malik","year":"2023","journal-title":"Front Endocrinol"},{"issue":"12","key":"10.1016\/j.diabres.2026.113544_b0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242749","article-title":"Heterogeneous expression ofCFTRin insulin-secreting \u03b2-cells of the normal human islet","volume":"15","author":"Di Fulvio","year":"2020","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.diabres.2026.113544_b0020","article-title":"Mediation of the total effect of cystic fibrosis-related diabetes on mortality: a UK Cystic Fibrosis Registry cohort study","volume":"39","author":"Kamaryn","year":"2022","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2026.113544_b0025","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01241-2023","article-title":"Cystic fibrosis in Europe: improved lung function and longevity - reasons for cautious optimism, but challenges remain","volume":"63","author":"Kerem","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.diabres.2026.113544_b0030","doi-asserted-by":"crossref","DOI":"10.1007\/s00125-025-06653-7","article-title":"The evolving understanding of cystic fibrosis-related diabetes in the highly effective modulator therapy era: a scoping revie","author":"Sharpe","year":"2026","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2026.113544_b0035","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.clinthera.2025.12.016","article-title":"Study of insulin treatment modalities in adults with cystic fibrosis-related diabetes after elexacaftor-tezacaftor-ivacaftor therapy","volume":"48","author":"Rakotoarisoa","year":"2026","journal-title":"Clin Ther"},{"key":"10.1016\/j.diabres.2026.113544_b0040","article-title":"One-Year effect of elexacaftor\/tezacaftor\/ivacaftortherapyon hba1c levels andinsulinrequirement in patients withinsulin-dependent cystic fibrosis-related diabetes: a retrospective observational study","volume":"16;14(10):1309","author":"Bassi","year":"2024","journal-title":"Life (Basel)"},{"key":"10.1016\/j.diabres.2026.113544_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2024.111839","article-title":"Impact of triple transmembrane regulator therapy on glucose metabolism in cystic fibrosis related diabetes during clinical practice","volume":"216","author":"Aguilera Garc\u00eda","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2026.113544_b0050","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1513\/AnnalsATS.202312-1065OC","article-title":"Multisystemic effects of elexacaftor-tezacaftor-ivacaftor in adults with cystic fibrosis and advanced lung disease","volume":"21","author":"Burgel","year":"2024","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.diabres.2026.113544_b0055","doi-asserted-by":"crossref","unstructured":"Ode LK, Ballman M, Battezzati A, et al. ISPAD Clinical Practice Consensus Guidelines 2022: Management of cystic fibrosis-related diabetes in children and adolescents Pediatr Diabetes 2022; 23:1212-1228. doi: 10.1111\/pedi.13453.","DOI":"10.1111\/pedi.13453"},{"key":"10.1016\/j.diabres.2026.113544_b0060","doi-asserted-by":"crossref","unstructured":"Sherwood JS, Castellanos LE, O\u2019Connor MY, et al. Randomized Trial of the Insulin-Only iLet Bionic Pancreas for the Treatment of Cystic Fibrosis\u2013Related Diabetes. Diabetes Care 2024; 47:101\u2013108 |https:\/\/doi.org\/10.2337\/dc23-1411.","DOI":"10.2337\/dc23-1411"},{"key":"10.1016\/j.diabres.2026.113544_b0065","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S2213-8587(17)30400-X","article-title":"CFRD Study Group. Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: a multicentre, open-label, randomised trial","volume":"6","author":"Ballmann","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabres.2026.113544_b0070","doi-asserted-by":"crossref","unstructured":"Moran A, Pekow P, Grover P, et al. Cystic Fibrosis Related Diabetes Therapy Study Group. Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial. Diabetes Care 2009 ;32 :1783-8. doi: 10.2337\/dc09-0585. Epub 2009 Jul 10.","DOI":"10.2337\/dc09-0585"},{"key":"10.1016\/j.diabres.2026.113544_b0075","doi-asserted-by":"crossref","unstructured":"Haahr H, Heise T. Fast\u2011Acting Insulin Aspart: A Review of its Pharmacokinetic and Pharmacodynamic Properties and the Clinical Consequences. 2020; 59:155\u2013172.","DOI":"10.1007\/s40262-019-00834-5"},{"key":"10.1016\/j.diabres.2026.113544_b0080","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2337\/dc16-1771","article-title":"Fast-acting insulin aspart improves glycemic control in basal-bolus treatment for type 1 diabetes: results of a 26-week multicenter, active-controlled, treat-to-target, randomized, parallel-group trial (onset 1)","volume":"40","author":"Russell-Jones","year":"2017","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.diabres.2026.113544_b0085","first-page":"255","article-title":"Efficacy and safety of fast-acting insulin aspart compared with insulin aspart, both in combination with insulin degludec, in children and adolescents with type 1 diabetes:the onset 7 trial","volume":"42","author":"Bode","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2026.113544_b0090","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/dom.13610","article-title":"A randomized, multicentre trial evaluating the efficacy and safety of fast-acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5)","volume":"21","author":"Klonoff","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2026.113544_b0095","first-page":"753","article-title":"Perceptions of diabetes technology use in cystic fibrosis-related diabetes management","volume":"23","author":"Marks","year":"2021","journal-title":"Diab Technol Therapautics"},{"key":"10.1016\/j.diabres.2026.113544_b0100","unstructured":"Senn S. Cross-over Trials in Clinical Research. Statistics in Practice, Wiley 2nd edition, 2008."},{"key":"10.1016\/j.diabres.2026.113544_b0105","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1210\/jc.2013-4417","article-title":"Pancreatic enzyme supplementation improves the incretin hormone response and attenuates postprandial glycemia in adolescents with cystic fibrosis: a randomized crossover trial","volume":"99","author":"Perano","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2026.113544_b0110","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1089\/dia.2024.0107","article-title":"Expert panel recommendations for a standardized ambulatory glucose profile report for connected insulin Pens","volume":"26","author":"Simonson","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2026.113544_b0115","doi-asserted-by":"crossref","unstructured":"Battelino T, Danne T, Bergenstal RM, et al. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care 2019;42:1593\u20131603 | https:\/\/doi.org\/10.2337\/dci19-0028.","DOI":"10.2337\/dci19-0028"},{"issue":"S3","key":"10.1016\/j.diabres.2026.113544_b0120","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1089\/dia.2023.0433","article-title":"Celebrating the data from 100,000 real-world users of the MiniMedTM 780G System In Europe, Middle East, and Africa collected over 3 years: from data to clinical evidence","volume":"26","author":"Choudhary","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2026.113544_b0125","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4093\/dmj.2024.0130","article-title":"Efficacy and safety of automated insulin delivery systems in patients with type 1 diabetes mellitus: a systematic review and meta-analysis","volume":"49","author":"Fan","year":"2025","journal-title":"Diabetes Metab Journal"},{"key":"10.1016\/j.diabres.2026.113544_b0130","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1089\/dia.2021.0354","article-title":"The effect of control IQ hybrid closed loop technology on glycemic control in adolescents and adults with cystic fibrosis-related diabetes","volume":"24","author":"Scully","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2026.113544_b0135","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1228153","article-title":"Effects of insulin therapy optimization with sensor augmented pumps on glycemic control and body composition in people with cystic fibrosis-related diabetes","volume":"14","author":"Grancini","year":"2023","journal-title":"Front Endocrinol"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882272600464X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882272600464X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:27:12Z","timestamp":1793122032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016882272600464X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":27,"alternative-id":["S016882272600464X"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113544","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Postprandial ultra-fast insulin versus mealtime fast-acting insulin in adults with cystic fibrosis-related diabetes: A randomized multicentre crossover trial","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113544","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113544"}}